Literature DB >> 142036

Effects of experimental diabetes and genetic obesity on regional blood flow in the rat.

P D Lucas, J M Foy.   

Abstract

Blood flow through various tissues of streptozotocin- and alloxan-diabetic and genetically obese rats was compared with that of controls by a radioisotopically labeled microsphere technique. Total cardiac output per unit body weight was unchanged in the diabetic group but decreased in the obese animals. The proportion of cardiac output received by the kidney and organs of the gastrointestinal tract was increased in the diabetic animals. Tissue hyperplasia appeared to be largely responsible. Blood flow per unit weight was markedly increased in the fat tissue of diabetic rats but was reduced in that of the obese rats, indicating a positive relationship between fat mobilization and blood flow. Blood flow in the hindlimbs, tail, skin, and spleen were all reduced in at least one diabetic group. Most of the changes observed appeared to progress with the duration of diabetes. Possible hormonal and metabolic causes are discussed. Some of the experimental changes observed may form useful models for diabetic vasculopathy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142036     DOI: 10.2337/diab.26.8.786

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Glomerular filtration rate and kidney blood flow in alloxan and streptozotocin diabetic rats.

Authors:  J M Foy; A K Salih
Journal:  Experientia       Date:  1979-08-15

Review 2.  Cardiometabolic crosstalk in obesity-associated arterial hypertension.

Authors:  Jens Jordan; Andreas L Birkenfeld
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

Review 3.  The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.

Authors:  P R Gwilt; R R Nahhas; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

4.  Effects of streptozotocin-induced diabetes and noradrenaline infusion on cardiac output and its regional distribution in pithed rats.

Authors:  P D Lucas
Journal:  Diabetologia       Date:  1985-02       Impact factor: 10.122

5.  The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus.

Authors:  R J Kiff; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

6.  Importance of hepatic portal circulation for insulin action in streptozotocin-diabetic rats transplanted with fetal pancreases.

Authors:  J Brown; Y Mullen; W R Clark; I G Molnar; D Heininger
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

7.  Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin.

Authors:  Joo H Lee; Myung G Lee
Journal:  Pharm Res       Date:  2008-05-14       Impact factor: 4.200

8.  The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats.

Authors:  P Robberecht; P De Neef; J C Camus; M Waelbroeck; J Fontaine; J Christophe
Journal:  Pflugers Arch       Date:  1983-08       Impact factor: 3.657

9.  Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.

Authors:  P Chatelain; P Robberecht; P De Neef; J C Camus; P Poloczek; J Christophe
Journal:  Pflugers Arch       Date:  1981-04       Impact factor: 3.657

10.  Study of the pharmacokinetic changes of Tramadol in diabetic rats.

Authors:  Hoda Lavasani; Behjat Sheikholeslami; Yalda H Ardakani; Mohammad Abdollahi; Lida Hakemi; Mohammad-Reza Rouini
Journal:  Daru       Date:  2013-03-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.